Terns is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of chronic liver diseases. Terns was founded in 2017. Terns' headquarters is located in Foster City, California, USA 94404.
Te... Terns's CEO, Senthil Sundaram, currently has an approval
rating of 90%. Terns's primary competitors are Intercept, Novartis & Amgen.
There have been no acquisitions found related to Terns
Recent investment data cannot be found related to Terns